Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
Here, Khurana et al. report the results of a phase 4 clinical trial with three FDA approved influenza vaccines and show that repeat influenza vaccination results in reduced antibody affinity maturation to hemagglutinin domain 1 irrespective of vaccine platform.
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/25c5be5b8b3340e9bfab6fabc559795c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!